Get started
Author

Dan Aderka

ESMO consensus guidelines for the management of patients with metastatic colorectal cancer
2016 · E. Van Cutsem, A. Cervantes, et al. · Annals of Oncology · 3,417
PDF
ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making
2012 · H.J. Schmoll, E. Van Cutsem, et al. · Annals of Oncology · 1,511
PDF
Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors.
1992 · D Aderka, H Engelmann, et al. · The Journal of Experimental Medicine · 814
PDF
IL-6 inhibits lipopolysaccharide-induced tumor necrosis factor production in cultured human monocytes, U937 cells, and in mice.
1989 · D Aderka, J Le, et al. · The Journal of Immunology · 574
Elevated tumour necrosis factor-alpha (TNF-α) biological activity in psoriatic skin lesions
1994 · P ETTEHADI, M W GREAVES, et al. · Clinical & Experimental Immunology · 481
A tumor necrosis factor-binding protein purified to homogeneity from human urine protects cells from tumor necrosis factor toxicity
1989 · H Engelmann, D Aderka, et al. · Journal of Biological Chemistry · 440
Overall survival and clinical characteristics of pancreatic cancer in BRCA mutation carriers
2014 · T Golan, Z S Kanji, et al. · British Journal of Cancer · 436
PDF
Increased levels of soluble tumor necrosis factor receptors in the sera and synovial fluid of patients with rheumatic diseases
1992 · Andrew P. Cope, Deena Gibbons, et al. · Arthritis & Rheumatism · 337
Soluble forms of tumor necrosis factor receptors (TNF‐Rs). The cDNA for the type I TNF‐R, cloned using amino acid sequence data of its soluble form, encodes both the cell surface and a soluble form of the receptor.
1990 · Y. Nophar, O. Kemper, et al. · The EMBO Journal · 331
PDF
The potential biological and clinical significance of the soluble tumor necrosis factor receptors
1996 · Dan Aderka · Cytokine & Growth Factor Reviews · 285
Increased serum levels of soluble receptors for tumor necrosis factor in cancer patients.
1991 · D Aderka, H Englemann, et al. · PubMed · 238
Distinguishing Features of Cetuximab and Panitumumab in Colorectal Cancer and Other Solid Tumors
2019 · Jesús García-Foncillas, Yu Sunakawa, et al. · Frontiers in Oncology · 201
PDF
Consensus molecular subgroups (CMS) of colorectal cancer (CRC) and first-line efficacy of FOLFIRI plus cetuximab or bevacizumab in the FIRE3 (AIO KRK-0306) trial
2019 · S. Stintzing, P. Wirapati, et al. · Annals of Oncology · 197
PDF
Letter: Thoracic-duct cannulation for bleeding oesophageal varices.
1976 · D Aderka · PubMed · 191
Correlation between serum levels of soluble tumor necrosis factor receptor and disease activity in systemic lupus erythematosus
1993 · Dan Aderka, Arjeh Wysenbeek, et al. · Arthritis & Rheumatism · 174
Tumor necrosis factor induction by Sendai virus.
1986 · D Aderka, H Holtmann, et al. · The Journal of Immunology · 167
Inhibition of pancreatic and lung adenocarcinoma cell survival by curcumin is associated with increased apoptosis, down-regulation of COX-2 and EGFR and inhibition of Erk1/2 activity.
2007 · Shahar Lev-Ari, Alex Starr, et al. · PubMed · 152
Variation in serum levels of the soluble TNF receptors among healthy individuals.
1992 · D Aderka, H Engelmann, et al. · PubMed · 144
Overall Survival and Clinical Characteristics of BRCA-Associated Cholangiocarcinoma: A Multicenter Retrospective Study
2017 · Talia Golan, Maria Raitses-Gurevich, et al. · The Oncologist · 128
Cachectin/tumour-necrosis-factor Production by Cancer Patients
1985 · Dan Aderka, Shimshon Fisher, et al. · The Lancet · 120
Idiopathic deep vein thrombosis in an apparently healthy patient as a premonitory sign of occult cancer
1986 · Dan Aderka, Abraham Brown, et al. · Cancer · 119
PDF
Curcumin Augments Gemcitabine Cytotoxic Effect on Pancreatic Adenocarcinoma Cell Lines
2007 · Shahar Lev-Ari, Akiva Vexler, et al. · Cancer Investigation · 118
Shedding kinetics of soluble tumor necrosis factor (TNF) receptors after systemic TNF leaking during isolated limb perfusion. Relevance to the pathophysiology of septic shock.
1998 · D Aderka, P Sorkine, et al. · Journal of Clinical Investigation · 115
Interleukin-6 inhibits the proliferation of B-chronic lymphocytic leukemia cells that is induced by tumor necrosis factor-alpha or -beta
1993 · D Aderka, Y Maor, et al. · Blood · 80
PDF
Bleeding Due to Thrombocytopenia in Acute Leukemias and Reevaluation of the Prophylactic Platelet Transfusion Policy
1986 · Dan Aderka, Giora Praff, et al. · The American Journal of the Medical Sciences · 77
Works count: 192
Citation count: 12,300
H-index: 36
I10-index: 73
Year
Topic
Type